Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Other Non Operating Income (2018 - 2024)

Lipocine's Other Non Operating Income history spans 7 years, with the latest figure at $3586.0 for Q4 2024.

  • For Q4 2024, Other Non Operating Income fell 70.78% year-over-year to $3586.0; the TTM value through Dec 2024 reached $17165.0, down 91.93%, while the annual FY2024 figure was $17166.0, 91.93% down from the prior year.
  • Other Non Operating Income reached $3586.0 in Q4 2024 per LPCN's latest filing, down from $138081.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $4.0 million in Q4 2021 to a low of -$3.8 million in Q2 2021.
  • Average Other Non Operating Income over 5 years is -$115155.6, with a median of $19864.5 recorded in 2023.
  • Peak YoY movement for Other Non Operating Income: crashed 2197.4% in 2020, then surged 6797.17% in 2021.
  • A 5-year view of Other Non Operating Income shows it stood at $57642.0 in 2020, then soared by 6797.17% to $4.0 million in 2021, then crashed by 99.14% to $34243.0 in 2022, then plummeted by 64.16% to $12274.0 in 2023, then tumbled by 70.78% to $3586.0 in 2024.
  • Per Business Quant, the three most recent readings for LPCN's Other Non Operating Income are $3586.0 (Q4 2024), $138081.0 (Q3 2024), and -$84430.0 (Q2 2024).